Search Bar & Filters
Found 4 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effect of a triple therapy inhaler containing budesonide, glycopyrronium, and formoterol fumarate BGF MDI 32014.49.6 g compared to a dual therapy inhaler with glycopyrronium and formoterol fumarate GFF MDI 14.49.6 g on heart and lung outcomes in adults with chronic obstructive pulmonary disease COPD who have increased cardiopulmonary risk. This is a Phase III randomized, double-blind, parallel group, multi-center study designed to assess these treatments over an extended period. Participants will be randomly assigned to receive either the triple therapy BGF MDI or the dual therapy GFF MDI, each administered twice daily. The study aims to track the time to first severe cardiac or COPD event over up to three years. Both treatments involve pressurized inhalation suspensions delivered by metered-dose inhalers, and the study includes ongoing monitoring for up to three years during which various cardiopulmonary events and exacerbations will be recorded. During the study, participants will attend visits where their inhaler technique, lung function, blood markers such as eosinophil counts, and COPD assessment test scores will be evaluated. Researchers will measure outcomes including time to severe COPD exacerbations, cardiac events, cardiopulmonary death, and hospitalizations related to heart issues. Safety and efficacy will be closely monitored throughout the study duration, which may last up to three years, with regular follow-up assessments conducted in person or virtually as needed.
Actively Recruiting
Researchers are evaluating a complex intervention to improve advance care planning ACP for severely ill elderly people living at home who are acutely admitted to hospital. This cluster randomized study involves twelve Norwegian geriatric hospital units and aims to enhance patient and family involvement in treatment decisions, improve quality of life, and support ethical and legal care planning. The project also explores barriers and facilitators to implementing ACP at clinical, health service, and governmental levels, including economic analyses. The intervention group receives a comprehensive support program that includes leadership commitment, training for staff, implementation teams, ACP coordinators, and practical tools such as guidelines and documentation templates. The control group receives no implementation support during the trial but will be offered the program afterward. The study period includes baseline, 9-month, and 18-month assessments for the intervention group and baseline and 18-month assessments for the control group. Participants will undergo questionnaires and interviews with patients, relatives, clinicians, and staff at multiple time points before, during, and after the implementation. Data from patient records and national health registers will be collected to assess the fidelity of ACP implementation, clinical outcomes, communication quality, and cost-effectiveness. The trial runs until December 2026 and includes various measures to evaluate the impact of the support program on ACP delivery and related outcomes.
Actively Recruiting
Researchers are evaluating the Sensory Motor Arousal Regulation Treatment SMART compared to usual treatment to support youth aged 7 to 17 years who have experienced complex trauma and struggle with self-regulation. This trial aims to see if SMART improves emotional, behavioral, and social regulation, reduces trauma and internalizing or externalizing symptoms, and strengthens psychosocial wellbeing. The study also explores how therapeutic relationships may influence treatment effects and differences among subgroups based on trauma exposure and age. Participants are randomly assigned to receive either SMART, which involves specialized sensory motor therapy in a dedicated room, or the best standard psychological treatment without SMART techniques. The study collects data at the start of treatment and follows up at 6 and 12 months to assess changes. The trial is conducted at multiple sites and includes 120 children and adolescents with developmental trauma and self-regulation difficulties. During the study, trained staff assess participants regulation difficulties, trauma symptoms, behavior, and overall functioning through various questionnaires and interviews at baseline and follow-ups. Researchers also measure the quality of the therapeutic relationship during treatment. The total participation spans over a year with evaluations at baseline, 6 months, and 12 months to understand the treatments short and longer-term impacts.
Actively Recruiting
Researchers are evaluating if vision training can improve functional vision in people who have lost part of their visual field due to stroke. The study also aims to understand how vision training affects participants perception of their visual abilities and their ability to compensate for visual field loss in daily activities, especially related to driving. This trial compares home-based vision training to standard care without training. Participants are assigned to either immediate or delayed vision training groups. The training involves daily 20-minute home exercises using online and manual oculomotor activities, scanning, and visual search tasks over 8 weeks. Weekly phone calls help maintain motivation and provide support. The delayed group starts training 8 weeks after baseline, allowing comparison between immediate and postponed intervention effects. Throughout the study, participants will be assessed at baseline, and at multiple points after training, including 8 weeks and up to 28 weeks depending on the group. Researchers will measure visual field reaction times, reading speed, quality of life, occupational performance, and vision function using specialized tools. Participants are asked to keep a training diary and will be monitored for changes in functional vision and the ability to compensate for visual field loss. Total participation lasts from 20 to 28 weeks.